大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/04 | 8,157 | 8,160 | 7,995 | 8,073 | +66 | +0.8% | 733,500 |
| 2025/02/03 | 7,986 | 8,051 | 7,854 | 8,007 | -129 | -1.6% | 1,022,200 |
| 2025/01/31 | 8,110 | 8,179 | 8,079 | 8,136 | +39 | +0.5% | 831,000 |
| 2025/01/30 | 8,145 | 8,195 | 8,061 | 8,097 | -98 | -1.2% | 1,435,000 |
| 2025/01/29 | 8,115 | 8,199 | 8,067 | 8,195 | +81 | +1% | 1,042,000 |
| 2025/01/28 | 8,070 | 8,239 | 8,070 | 8,114 | +80 | +1% | 1,038,700 |
| 2025/01/27 | 8,051 | 8,121 | 8,014 | 8,034 | +28 | +0.3% | 798,100 |
| 2025/01/24 | 8,016 | 8,030 | 7,949 | 8,006 | +56 | +0.7% | 762,500 |
| 2025/01/23 | 7,970 | 7,992 | 7,912 | 7,950 | -52 | -0.6% | 834,800 |
| 2025/01/22 | 8,051 | 8,066 | 7,944 | 8,002 | -14 | -0.2% | 884,000 |
| 2025/01/21 | 8,025 | 8,087 | 7,972 | 8,016 | +9 | +0.1% | 628,400 |
| 2025/01/20 | 7,949 | 8,036 | 7,926 | 8,007 | +45 | +0.6% | 777,300 |
| 2025/01/17 | 7,970 | 8,000 | 7,925 | 7,962 | -42 | -0.5% | 980,000 |
| 2025/01/16 | 8,081 | 8,118 | 8,004 | 8,004 | -59 | -0.7% | 800,300 |
| 2025/01/15 | 8,121 | 8,216 | 8,013 | 8,063 | +12 | +0.1% | 939,200 |
| 2025/01/14 | 7,940 | 8,074 | 7,817 | 8,051 | -12 | -0.1% | 1,685,500 |
| 2025/01/10 | 8,383 | 8,431 | 8,035 | 8,063 | -351 | -4.2% | 1,759,200 |
| 2025/01/09 | 8,362 | 8,453 | 8,348 | 8,414 | +5 | +0.1% | 869,800 |
| 2025/01/08 | 8,450 | 8,519 | 8,320 | 8,409 | -102 | -1.2% | 1,160,600 |
| 2025/01/07 | 8,450 | 8,631 | 8,428 | 8,511 | +101 | +1.2% | 849,800 |
| 2025/01/06 | 8,601 | 8,625 | 8,363 | 8,410 | -190 | -2.2% | 1,162,200 |
| 2024/12/30 | 8,657 | 8,673 | 8,577 | 8,600 | -57 | -0.7% | 817,400 |
| 2024/12/27 | 8,600 | 8,716 | 8,574 | 8,657 | +21 | +0.2% | 1,153,900 |
| 2024/12/26 | 8,560 | 8,663 | 8,555 | 8,636 | +51 | +0.6% | 1,145,900 |
| 2024/12/25 | 8,593 | 8,611 | 8,503 | 8,585 | -9 | -0.1% | 654,100 |
| 2024/12/24 | 8,587 | 8,627 | 8,571 | 8,594 | -6 | -0.1% | 449,700 |
| 2024/12/23 | 8,475 | 8,640 | 8,464 | 8,600 | +117 | +1.4% | 785,500 |
| 2024/12/20 | 8,520 | 8,535 | 8,376 | 8,483 | -51 | -0.6% | 2,780,100 |
| 2024/12/19 | 8,521 | 8,641 | 8,521 | 8,534 | -75 | -0.9% | 680,800 |
| 2024/12/18 | 8,610 | 8,674 | 8,597 | 8,609 | +2 | ±0% | 858,300 |
| 2024/12/17 | 8,710 | 8,736 | 8,570 | 8,607 | -133 | -1.5% | 1,064,400 |
| 2024/12/16 | 8,689 | 8,767 | 8,673 | 8,740 | +51 | +0.6% | 728,700 |
| 2024/12/13 | 8,710 | 8,846 | 8,608 | 8,689 | -158 | -1.8% | 1,518,000 |
| 2024/12/12 | 8,839 | 8,931 | 8,780 | 8,847 | +107 | +1.2% | 1,132,700 |
| 2024/12/11 | 8,888 | 8,938 | 8,707 | 8,740 | -58 | -0.7% | 1,136,800 |
| 2024/12/10 | 8,909 | 8,910 | 8,750 | 8,798 | +14 | +0.2% | 853,400 |
| 2024/12/09 | 8,885 | 8,938 | 8,747 | 8,784 | -24 | -0.3% | 1,014,600 |
| 2024/12/06 | 9,093 | 9,099 | 8,700 | 8,808 | -252 | -2.8% | 992,200 |
| 2024/12/05 | 8,962 | 9,074 | 8,930 | 9,060 | +118 | +1.3% | 927,000 |
| 2024/12/04 | 9,155 | 9,161 | 8,883 | 8,942 | -214 | -2.3% | 1,132,600 |
| 2024/12/03 | 8,948 | 9,211 | 8,915 | 9,156 | +307 | +3.5% | 1,496,700 |
| 2024/12/02 | 8,686 | 8,938 | 8,686 | 8,849 | +164 | +1.9% | 1,029,800 |
| 2024/11/29 | 8,663 | 8,789 | 8,618 | 8,685 | -3 | ±0% | 870,100 |
| 2024/11/28 | 8,600 | 8,700 | 8,588 | 8,688 | +25 | +0.3% | 845,000 |
| 2024/11/27 | 8,716 | 8,725 | 8,600 | 8,663 | +50 | +0.6% | 1,097,000 |
| 2024/11/26 | 8,724 | 8,759 | 8,513 | 8,613 | -186 | -2.1% | 1,243,800 |
| 2024/11/25 | 9,000 | 9,060 | 8,799 | 8,799 | -111 | -1.2% | 3,199,500 |
| 2024/11/22 | 8,938 | 8,996 | 8,840 | 8,910 | -42 | -0.5% | 1,053,200 |
| 2024/11/21 | 9,071 | 9,180 | 8,952 | 8,952 | -48 | -0.5% | 989,200 |
| 2024/11/20 | 8,755 | 9,044 | 8,725 | 9,000 | +238 | +2.7% | 1,342,200 |
51～
100
件表示中 / 3509件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 683,000円 | +2.2% | +10.2% | 1.76% | 13.16倍 | 1.33倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 武 田 | 428,800円 | +7.7% | +206.9% | 4.57% | 57.34倍 | 0.98倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 第一三共 | 321,400円 | +14.3% | +26.5% | 1.87% | 25.16倍 | 3.69倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| アステラス薬 | 135,200円 | +18.5% | -96.0% | 5.47% | 172.89倍 | 1.58倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 240,800円 | +5.7% | +3.9% | 2.38% | 11.98倍 | 1.59倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
